Onemednet CORP (ONMDW) — SEC Filings

Overview

Onemednet CORP (ONMDW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 23, 2025: On December 17, 2025, OneMedNet Corp. filed an 8-K report detailing a shareholder vote on matters presented for approval. The company, formerly known as Data Knights Acquisition Corp., is incorporated in Delaware and operates in the commercial physical and biological research sector.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bullish, 13 bearish, 36 neutral. The dominant filing sentiment for Onemednet CORP is neutral.

Filing Type Overview

Onemednet CORP (ONMDW) has filed 31 8-K, 6 10-Q, 5 S-1/A, 2 10-K, 1 8-K/A, 3 SC 13G, 1 DEF 14A, 1 10-K/A with the SEC between Mar 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

• OneMedNet Corp. Files 8-K on Shareholder Vote — 8-K · Dec 23, 2025 Risk: low
  On December 17, 2025, OneMedNet Corp. filed an 8-K report detailing a shareholder vote on matters presented for approval. The company, formerly known as Data Kn
• OneMedNet Swings to Profit on Debt Restructuring, Revenue Dips 24% — 10-Q · Nov 14, 2025 Risk: high
  OneMedNet Corp (ONMDW) reported a net income of $339,000 for the nine months ended September 30, 2025, a significant improvement from a net loss of $7.756 milli
• OneMedNet Corp. Announces Director and Officer Changes — 8-K · Nov 7, 2025 Risk: medium
  OneMedNet Corp. announced on November 6, 2025, changes related to its board of directors and officers, including the election of new directors and adjustments t
• OneMedNet Corp. Acquires AI Medical Imaging Solutions Provider — 8-K · Oct 9, 2025 Risk: medium
  OneMedNet Corp. announced on October 8, 2025, that it has entered into a definitive agreement to acquire substantially all of the assets of a company, which is
• OneMedNet Corp. Files 8-K: "Other Event" Announced — 8-K · Sep 15, 2025 Risk: medium
  On September 11, 2025, OneMedNet Corp. announced an "Other Event" in a Form 8-K filing. The filing does not contain specific details regarding the nature of thi
• OneMedNet Swings to Profit on Debt Restructuring, Revenue Dips — 10-Q · Aug 13, 2025 Risk: high
  OneMedNet Corp (ONMDW) reported a net income of $2.982 million for the three months ended June 30, 2025, a significant improvement from a net loss of $3.589 mil
• OneMedNet Q1 Revenue Jumps 20% Amidst Persistent Losses — S-1/A · Jul 14, 2025 Risk: high
  OneMedNet Corp (ONMDW) reported a significant increase in total revenue for Q1 2025, reaching $1,200,000, a 20% rise from $1,000,000 in Q1 2024. This growth was
• OneMedNet Corp. Files 8-K — 8-K · Jul 11, 2025 Risk: low
  OneMedNet Corp. filed an 8-K on July 11, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Data Knights Acqu
• OneMedNet Corp. Files 8-K Report — 8-K · Jul 8, 2025 Risk: low
  On July 8, 2025, OneMedNet Corp. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company was
• OneMedNet Doubles Q1 Revenue, Driven by Subscription & Web Imaging Growth — S-1/A · Jun 25, 2025 Risk: medium
  OneMedNet Corp (ONMDW) reported a significant increase in subscription revenue for the three months ended March 31, 2025, reaching $1,000,000, up from $500,000
• OneMedNet Corp. Enters Material Definitive Agreement — 8-K · Jun 24, 2025 Risk: medium
  On June 17, 2025, OneMedNet Corp. entered into a material definitive agreement related to unregistered sales of equity securities. The company, formerly known a
• OneMedNet Corp. Files Q1 2025 10-Q — 10-Q · May 14, 2025 Risk: medium
  OneMedNet Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Data Knights Acquisition Corp., reported financial results f
• 10-K Filing — 10-K · Apr 15, 2025
• OneMedNet Corp. Faces Delisting Notice — 8-K · Mar 14, 2025 Risk: high
  OneMedNet Corp. reported on March 12, 2025, that it received a notice regarding its failure to meet a continued listing rule or standard, potentially leading to
• OneMedNet Corp Adds Two Directors to Board — 8-K · Mar 3, 2025 Risk: low
  On February 25, 2025, OneMedNet Corp. announced the election of two new directors, Dr. Jonathan S. Rothberg and Mr. David M. S. Johnson, to its Board of Directo
• OneMedNet Corp. Reports Director and Officer Changes — 8-K · Feb 6, 2025 Risk: medium
  OneMedNet Corp. announced on January 31, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain
• OneMedNet Corp Files S-1/A Amendment — S-1/A · Feb 3, 2025 Risk: medium
  OneMedNet Corp filed an S-1/A on February 3, 2025, to update its registration statement. The company, formerly known as Data Knights Acquisition Corp. until Mar
• OneMedNet Corp. Files 8-K: Regulation FD & Financials — 8-K · Dec 30, 2024 Risk: low
  On December 23, 2024, OneMedNet Corp. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly know
• OneMedNet Corp. Files 8-K on Security Holder Vote Matters — 8-K · Dec 20, 2024 Risk: medium
  On December 19, 2024, OneMedNet Corp. filed an 8-K report detailing the submission of matters to a vote of its security holders. The company, formerly known as
• OneMedNet Corp Files Q3 2024 10-Q — 10-Q · Dec 17, 2024 Risk: medium
  OneMedNet Corp filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Data Knights Acquisition Corp., reported financial result
• OneMedNet Corp Files Q2 2024 10-Q — 10-Q · Dec 11, 2024 Risk: medium
  OneMedNet Corp filed its 10-Q for the period ending June 30, 2024. The company, formerly Data Knights Acquisition Corp., is incorporated in Delaware and operate
• OneMedNet Corp Files Q1 2024 10-Q — 10-Q · Dec 5, 2024 Risk: medium
  OneMedNet Corp filed its Q1 2024 10-Q report on December 5, 2024, covering the period ending March 31, 2024. The company, formerly Data Knights Acquisition Corp
• OneMedNet Corp. Files 8-K on Delisting Concerns — 8-K · Nov 27, 2024 Risk: high
  OneMedNet Corp. filed an 8-K on November 27, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed fi
• OneMedNet Corp Files 8-K/A Amendment — 8-K/A · Nov 22, 2024 Risk: low
  OneMedNet Corp filed an amendment (8-K/A) on November 22, 2024, to its report originally dated November 7, 2023. This amendment pertains to financial statements
• SC 13G Filing — SC 13G · Nov 12, 2024
• OneMedNet Corp. Files Definitive Proxy Statement — DEF 14A · Nov 8, 2024 Risk: low
  OneMedNet Corp. is filing its definitive proxy statement (DEF 14A) on November 8, 2024, for the fiscal year ending December 31, 2024. The company, formerly know
• OneMedNet Corp. Files 2023 10-K Amendment — 10-K/A · Nov 5, 2024 Risk: medium
  OneMedNet Corp. filed an amendment to its 2023 10-K on November 5, 2024, reporting financial data for the fiscal year ending December 31, 2023. The company, for
• OneMedNet Corp. Faces Delisting Notice — 8-K · Oct 17, 2024 Risk: high
  OneMedNet Corp. received a notice on October 16, 2024, indicating a failure to meet continued listing requirements. The company was formerly known as Data Knigh
• OneMedNet Corp. Faces Delisting Notice — 8-K · Oct 15, 2024 Risk: high
  OneMedNet Corp. received a notice on October 8, 2024, indicating a failure to meet continued listing standards for its common stock. The company, formerly known
• OneMedNet Appoints Dr. Jonathan Rothberg as New CEO — 8-K · Oct 7, 2024 Risk: medium
  OneMedNet Corp. announced on October 1, 2024, the appointment of Dr. Jonathan Rothberg as Chief Executive Officer, succeeding Dr. Elias Zerhouni. Dr. Rothberg,
• OneMedNet Corp. Enters Material Definitive Agreement — 8-K · Oct 1, 2024 Risk: medium
  On September 24, 2024, OneMedNet Corp. entered into a Material Definitive Agreement related to the unregistered sale of equity securities. The company, formerly
• SC 13G Filing — SC 13G · Oct 1, 2024
• OneMedNet Corp. Faces Delisting Notice — 8-K · Sep 12, 2024 Risk: high
  OneMedNet Corp. received a notice of delisting or failure to satisfy a continued listing rule or standard on September 9, 2024. The company was formerly known a
• OneMedNet Appoints Former Allergan CEO Pyott to Board — 8-K · Aug 30, 2024 Risk: medium
  OneMedNet Corp. announced on August 26, 2024, the appointment of Dr. David E.I. Pyott as a new director. Dr. Pyott brings extensive experience from his tenure a
• OneMedNet Corp. Faces Nasdaq Delisting Notice — 8-K · Aug 16, 2024 Risk: high
  OneMedNet Corp. announced on August 15, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing requirements
• OneMedNet Corp. Reports Board and Officer Changes — 8-K · Aug 14, 2024 Risk: low
  OneMedNet Corp. announced on August 12, 2024, changes in its board and officer compensation. Specifically, the company elected new directors and adjusted compen
• SC 13G Filing — SC 13G · Aug 5, 2024
• OneMedNet Corp. Files 8-K: Material Agreement, Equity Sales — 8-K · Jul 29, 2024 Risk: medium
  On July 23, 2024, OneMedNet Corp. entered into a Material Definitive Agreement related to the sale of its common stock. The company also disclosed unregistered
• OneMedNet Corp. Faces Nasdaq Delisting Warning — 8-K · Jun 24, 2024 Risk: high
  OneMedNet Corp. announced on June 20, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing requirements.
• OneMedNet Corp. Enters and Terminates Agreements, Creates Obligation — 8-K · Jun 21, 2024 Risk: medium
  On June 14, 2024, OneMedNet Corp. entered into a Material Definitive Agreement and created a direct financial obligation. The company also terminated a Material
• OneMedNet Corp. Faces Nasdaq Delisting Notice — 8-K · Jun 14, 2024 Risk: high
  OneMedNet Corp. announced on June 10, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing requirements.
• OneMedNet Corp. Enters Material Definitive Agreement — 8-K · Jun 6, 2024 Risk: medium
  On June 4, 2024, OneMedNet Corp. entered into a Material Definitive Agreement. The company, formerly known as Data Knights Acquisition Corp., is incorporated in
• OneMedNet Restates Financials Due to Accountant Change — 8-K · Jun 4, 2024 Risk: high
  OneMedNet Corporation announced on June 3, 2024, that it will not rely on previously issued financial statements or related audit reports. This decision stems f
• OneMedNet Corp 8-K: Office Location and Stock Info — 8-K · May 23, 2024 Risk: low
  On May 23, 2024, OneMedNet Corporation (ONMD) filed an 8-K report. The filing details the company's principal executive offices located at 6385 Old Shady Oak Ro
• OneMedNet Appoints BDO USA as New Auditor — 8-K · May 10, 2024 Risk: low
  OneMedNet Corporation has appointed BDO USA, P.A. as its new independent registered public accounting firm, effective May 6, 2024. This change follows the resig
• OneMedNet Corp. Files S-1/A Amendment — S-1/A · May 7, 2024 Risk: low
  OneMedNet Corp (ONMDW) filed a Amended IPO Registration (S-1/A) with the SEC on May 7, 2024. OneMedNet Corp. filed an S-1/A amendment on May 7, 2024. The compan
• OneMedNet Corp. Files S-1/A Amendment — S-1/A · Apr 17, 2024 Risk: low
  OneMedNet Corp (ONMDW) filed a Amended IPO Registration (S-1/A) with the SEC on April 17, 2024. OneMedNet Corp. (formerly Data Knights Acquisition Corp.) filed
• OneMedNet Corp. Files 2023 Annual Report on Form 10-K — 10-K · Apr 9, 2024 Risk:
  OneMedNet Corp (ONMDW) filed a Annual Report (10-K) with the SEC on April 9, 2024. OneMedNet Corp. filed its 2023 Form 10-K on April 9, 2024. The filing covers
• OneMedNet Corp. Sells Subsidiary, Discloses Equity Sales & Officer Changes — 8-K · Apr 2, 2024 Risk: medium
  OneMedNet Corp. announced on March 27, 2024, the entry into a material definitive agreement related to the sale of its wholly-owned subsidiary, OneMedNet Soluti
• OneMedNet Faces Nasdaq Delisting Notice — 8-K · Mar 29, 2024 Risk: high
  OneMedNet Corp. announced on March 26, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing requirements.

Risk Profile

Risk Assessment: Of ONMDW's 45 recent filings, 13 were flagged as high-risk, 20 as medium-risk, and 12 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Onemednet CORP's most recent 10-Q filing (Nov 14, 2025):

• Revenue: $468,000
• Net Income: $339,000
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $149,000
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: $5.445 million

Key Executives

• Eden Prairie, Minnesota
• Dr. Jonathan S. Rothberg
• Mr. David M. S. Johnson
• Dr. Jonathan Rothberg
• Dr. Elias Zerhouni
• Dr. David E.I. Pyott

Industry Context

The healthcare technology sector is highly competitive, with companies striving to innovate in areas like data management and AI-driven diagnostics. OneMedNet operates in a space where regulatory compliance, data security, and the ability to demonstrate clear value propositions are critical for success. The industry is characterized by significant R&D investment and a need for continuous technological advancement to meet evolving healthcare demands.

Top Tags

delisting (9) · financials (7) · corporate-governance (5) · listing-standards (5) · corporate-action (4) · 10-Q (4) · compliance (4) · 8-k (3) · 8-K (3) · corporate-actions (3)

Key Numbers

• SEC File Number: 001-40386 — Identifies the company's filing history with the SEC.
• EIN: 86-2076743 — Employer Identification Number for tax purposes.
• Net income: $339,000 — For the nine months ended September 30, 2025, a significant improvement from a $7.756 million net loss in 2024.
• Total revenue: $468,000 — For the nine months ended September 30, 2025, a 24.1% decrease from $617,000 in 2024.
• Gain on troubled debt restructurings: $5.569 million — A primary driver of the net income for the nine months ended September 30, 2025.
• Realized gain on sale of crypto assets – Bitcoin: $899,000 — Contributed to the net income for the nine months ended September 30, 2025.
• Total liabilities: $5.445 million — As of September 30, 2025, a substantial decrease from $19.677 million at December 31, 2024.
• Total stockholders' deficit: $3.939 million — As of September 30, 2025, indicating ongoing financial challenges despite net income.
• Net cash used in operating activities: $5.790 million — For the nine months ended September 30, 2025, an increase from $4.956 million in 2024.
• Cash and cash equivalents: $149,000 — As of September 30, 2025, a decrease from $172,000 at the beginning of the period.
• Shares of common stock outstanding: 51,005,205 — As of November 7, 2025, reflecting significant share issuance through debt conversions.
• Subscription revenue: $105,000 — For the nine months ended September 30, 2025, a sharp decline from $443,000 in 2024.
• Net Income (Q2 2025): $2.982M — Significant swing from -$3.589M net loss in Q2 2024, primarily due to debt restructuring.
• Net Income (YTD Q2 2025): $1.080M — Reversed -$5.698M net loss from YTD Q2 2024, largely from non-operating gains.
• Total Revenue (Q2 2025): $155K — Decreased from $227K in Q2 2024, indicating declining core business.

Related Companies

ONMD · ONMT

Frequently Asked Questions